XML 39 R26.htm IDEA: XBRL DOCUMENT v3.20.2
Subsequent Events
6 Months Ended
Jun. 30, 2020
Subsequent Events [Abstract]  
Subsequent Events [Text Block]
Note 20 – COVID-19 Global Pandemic
In early 2020, a global outbreak of COVID-19 occurred
 
initially in China and then across all locations where the Company does
business, and which is continuing into the second half of
 
the year.
 
In March 2020, the World
 
Health Organization formally identified
the COVID-19 outbreak as a pandemic.
 
In an effort to halt the outbreak of COVID-19, the governments
 
of impacted countries,
including but not limited to the United States, the European
 
Union, and China, have taken various actions to reduce
 
its spread,
including travel restrictions, shutdowns of businesses deemed
 
nonessential, and stay-at-home or similar orders.
 
This outbreak and
associated measures to reduce its spread have caused
 
significant disruptions
 
to the operations of the Company and its suppliers and
customers.
 
The disruptions and negative impact to the Company
 
include significant volume declines and lower net sales first at its
China subsidiaries in the first quarter of 2020 and
 
subsequently, particularly
 
beginning in the second half of March and into the second
quarter, at many of its other
 
sites globally as the global economy slowed significantly in response
 
to the pandemic.
 
Management
continues to monitor the impact that the COVID-19 pandemic
 
is having on the Company,
 
the overall specialty chemical industry,
 
and
the economies and markets in which the Company operates.
Further, management continues to
 
evaluate how COVID-19-related circumstances, such as remote
 
work arrangements, have
affected financial reporting processes, internal control
 
over financial reporting, and disclosure controls and procedures.
 
While the
circumstances have presented and are expected to continue
 
to present challenges, at this time, management does not believe
 
that
COVID-19 has had a material impact on financial reporting
 
processes, internal controls over financial reporting, and
 
disclosure
controls and procedures.
 
The full extent of the COVID-19 pandemic related
 
business and travel restrictions and changes to business and
 
consumer
behavior intended to reduce its spread are uncertain as of
 
the date of this Report as COVID-19 and the responses of governmental
authorities continue to rapidly evolve globally.
 
The Company cannot reasonably estimate the magnitude of the effects
 
these
conditions will have on the Company’s
 
operations as they are subject to significant uncertainties relating to
 
the ultimate geographic
spread of the virus, the incidence and severity of
 
the disease, the duration or recurrence of the outbreak, the
 
length of the travel
restrictions and business closures imposed by governments
 
of impacted countries, and the economic response by governments
 
of
impacted countries.
 
To the extent
 
that the Company’s customers and
 
suppliers continue to be significantly and adversely impacted by
 
COVID-19, this
could reduce the availability,
 
or result in delays, of materials or supplies to or from
 
the Company, which in
 
turn could significantly
interrupt the Company’s
 
business operations.
 
Such impacts could grow and become more significant to the
 
Company’s operations
and the Company’s liquidity
 
or financial position.
 
Therefore, given the speed and frequency of continuously
 
evolving developments
with respect to this pandemic, the Company cannot reasonably
 
estimate the magnitude or the full extent to which COVID-19
 
may
impact the Company’s results
 
of operations, liquidity or financial position.